RxDoctor Payments Data

Johnnie Parker

Family · Rolla, MONPI 1073051942

Payments from drug & device makers

$1,226in general payments, 2019–2025

Across 75 payments — averaging $16.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$300
  • Lilly USA, LLC$197
  • Gilead$165
  • Alkermes, Inc.$95
  • Braeburn Inc.$91
  • Pfizer$87
  • plus $291 from 9 others

What the payments were for

  • Food & beverage$1,19998%
  • Education$272%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,226 in reported general payments places this provider in the 70th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$469
Medicare patients
24
Services billed
37

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin111$97,758
TrulicityDulaglutide67$74,389
MounjaroTirzepatide45$48,679
EntrestoSacubitril/Valsartan24$26,112
EliquisApixaban33$24,293
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$19,709
LinzessLinaclotide32$18,592
OzempicSemaglutide18$18,172
Tresiba Flextouch U-200Insulin Degludec12$17,279
XareltoRivaroxaban25$16,789
Combivent RespimatIpratropium/Albuterol Sulfate25$12,356
Repatha SyringeEvolocumab20$11,536
Zileuton ErZileuton12$8,336
SuboxoneBuprenorphine Hcl/Naloxone Hcl14$6,843
SymbicortBudesonide/Formoterol Fumarate25$6,407

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$197$123,068112 claims
PfizerEliquis$87$24,29333 claims
GSKTrelegy Ellipta$17$19,70916 claims
AbbVieLinzess$300$18,59232 claims
Johnson & JohnsonXarelto$14$16,78925 claims
Indivior Inc.Suboxone$61$6,84314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,812 family providers in Missouri.

Other family in Rolla

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →